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The structure of the title compound, 2-methyl-1-(1,2,3,9-
tetrahydro-9-methyl-4-oxo-4H-carbazol-3-ylmethyl)-1H-imid-
azol-3-ium chloride dihydrate, C18H24N3
+Clÿ2H2O, has been
reported previously by Collin, Moureau, Quintero, Vercau-
teren, Evrard & Durant [(1995). J. Chem. Soc. Perkin Trans. 2,
pp. 77±84] and Chandra Mohan & Ravikumar, [(1995), Acta
Cryst. C51, 2627±2629]. In both determinations, all atoms were
re®ned as clearly ordered. In contrast to this, we present here a
redetermination of this structure from new intensity data
where two atoms of the cyclohexenone ring are disordered
over two sites. Apart from this disorder, our results agree with
the already published data.
Comment
The title compound, (I), is an anti-emetic, which has been
described by Milne & Heel (1991). It is a highly selective 5-
HT3 receptor antagonist (Ye et al., 2001). A perspective view
is shown in Fig. 1.
The structure of (I) has already been determined twice at
room temperature by two different research groups (Collin et
al., 1995; Chandra Mohan & Ravikumar, 1995). Both of these
structures were re®ned as perfectly ordered. However, we
have collected data at low temperature and discovered that
two atoms of the cyclohexenone ring are disordered over two
sites. In order to check if the crystal had undergone a phase
transition upon cooling, a data set was collected on a different
crystal at room temperature. This crystal showed the same
disorder as the crystal investigated at low temperature. As a
result, a phase transition can be ruled out. A closer look at
both published ordered structures shows that the displace-
ment ellipsoids of the atoms in question (C2 and C3 in the
present structure) are elongated, which suggest disorder.
Furthermore, the bond length between these atoms is signi®-
cantly shortened in the two published structures (1.479 and
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1.485 AÊ ) compared with the value [1.536 (3) AÊ ] we found in
the major component. This indicates an average of two posi-
tions for the two atoms. As a result, the previous structures
seem to be disordered as well, but were not re®ned as such.
Apart from this disorder, our results agree with the already
published data. Bond lengths and angles can be regarded as
normal (Cambridge Structural Database, Version 1.6 plus
three updates; Mogul Version 1.0; Allen, 2002).
Experimental
The sample of the title compound was obtained as a gift from CIPLA,
India. It was used without further puri®cation and recrystallized from
methanol to give colourless blocks.
Crystal data
C18H20N3O
+Clÿ2H2O
Mr = 365.85
Monoclinic, P21=c
a = 15.0216 (13) AÊ
b = 9.6464 (8) AÊ
c = 12.6545 (10) AÊ
 = 100.708 (6)
V = 1801.8 (3) AÊ 3
Z = 4
Dx = 1.349 Mg m
ÿ3
Mo K radiation
Cell parameters from 20705
re¯ections
 = 3.7±27.6
 = 0.23 mmÿ1
T = 173 (2) K
Block, colourless
0.33  0.27  0.14 mm
Data collection
Stoe IPDS-II two-circle
diffractometer
! scans
Absorption correction: multi-scan
(MULABS; Spek, 1990; Blessing,
1995)
Tmin = 0.928, Tmax = 0.967
24157 measured re¯ections
4181 independent re¯ections
3172 re¯ections with I > 2(I)
Rint = 0.058
max = 27.7

h = ÿ19! 19
k = ÿ12! 12
l = ÿ16! 16
Refinement
Re®nement on F 2
R[F 2 > 2(F 2)] = 0.033
wR(F 2) = 0.087
S = 0.96
4181 re¯ections
267 parameters
H atoms treated by a mixture of
independent and constrained
re®nement
w = 1/[2(Fo
2) + (0.0567P)2]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 0.24 e AÊ
ÿ3
min = ÿ0.21 e AÊ ÿ3
Table 1
Hydrogen-bonding geometry (AÊ , ).
DÐH  A DÐH H  A D  A DÐH  A
N23ÐH23  O1W 0.92 (2) 1.75 (2) 2.6663 (16) 178.0 (19)
O1WÐH1WB  Cl1 0.82 (2) 2.32 (2) 3.1252 (14) 166 (2)
O2WÐH2WB  Cl1 0.89 (3) 2.33 (3) 3.2171 (15) 175 (2)
O1WÐH1WA  Cl1i 0.85 (3) 2.32 (3) 3.1334 (14) 161 (2)
O2WÐH2WA  Cl1ii 0.82 (3) 2.41 (3) 3.2205 (15) 172 (2)
Symmetry codes: (i) ÿx; yÿ 12; 12ÿ z; (ii) ÿx; 1ÿ y;ÿz.
The site-occupation factors of the disordered atoms re®ned to
0.791 (6) and 0.209 (6). In the second crystal examined at room
temperature, the ratio of the site-occupation factors re®ned to
0.759 (9)/0.241 (9). H atoms were re®ned with ®xed individual
displacement parameters [Uiso(H) = 1.2Ueq(C) or 1.5Ueq(Cmethyl)]
using a riding model, with CÐH = 1.00 AÊ , CÐH = 0.99 AÊ , CÐH =
0.98 and 0.95 AÊ , for tertiary CH, secondary CH, methyl CH and
aromatic CH, respectively. The methyl groups were allowed to rotate
but not to tip. H atoms bonded to O and N atoms were re®ned
isotropically.
Data collection: X-AREA (Stoe & Cie, 2001); cell re®nement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SHELXS97 (Sheldrick, 1990); program(s) used to re®ne
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: XP in
SHELXTL-Plus (Sheldrick, 1991); software used to prepare material
for publication: SHELXL97 and PLATON (Spek, 2003).
One of the authors (HSY) thanks CIPLA, Mumbai, for a
gift sample of ondansetron hydrochloride dihydrate.
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Figure 1
Perspective view of the title compound, with the atom numbering.
Displacement ellipsoids are drawn at the 50% probability level.
